Herceptin

In the US, Herceptin (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.

US matches:

UK matches:

Ingredient matches for Herceptin

Trastuzumab

Trastuzumab is reported as an ingredient of Herceptin in the following countries:

  • Argentina
  • Armenia
  • Australia
  • Austria
  • Bahrain
  • Bangladesh
  • Belgium
  • Bolivia
  • Bosnia & Herzegowina
  • Brazil
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia (Hrvatska)
  • Cuba
  • Cyprus
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Finland
  • France
  • Georgia
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Kazakhstan
  • Kuwait
  • Latvia
  • Lebanon
  • Lithuania
  • Luxembourg
  • Mexico
  • Moldova
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Paraguay
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Thailand
  • Trinidad & Tobago
  • Tunisia
  • Turkey
  • United Arab Emirates
  • United Kingdom
  • United States
  • Uruguay
  • Uzbekistan
  • Venezuela
  • Yemen

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web3)